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SUMMARY
Selenof (15-kDa selenoprotein; Sep15) is an endo-
plasmic reticulum (ER)-resident thioredoxin-like
oxidoreductase that occurs in a complex with UDP-
glucose:glycoprotein glucosyltransferase. We found
that Selenof deficiency in mice leads to elevated
levels of non-functional circulating plasma immuno-
globulins and increased secretion of IgM during
in vitro splenic B cell differentiation. However, Sele-
nof knockout animals show neither enhanced bacte-
rial killing capacity nor antigen-induced systemic IgM
activity, suggesting that excess immunoglobulins are
not functional. In addition, ER-to-Golgi transport of a
target glycoprotein was delayed in Selenof knockout
embryonic fibroblasts, and proteomic analyses re-
vealed that Selenof deficiency is primarily associated
with antigen presentation and ER-to-Golgi transport.
Together, the data suggest that Selenof functions as
a gatekeeper of immunoglobulins and, likely, other
client proteins that exit the ER, thereby supporting
redox quality control of these proteins.
INTRODUCTION
Selenium is an essential trace element due to its occurrence in
proteins in the form of selenocysteine (Sec, U). Sec is known
as the 21st amino acid encoded by a UGA codon; it is inserted
co-translationally into nascent polypeptides with the help of
the Sec insertion sequence (SECIS) element (Berry et al.,
1991). There are 25 selenoprotein genes in humans and 24 in
mice and most other mammals (Kryukov et al., 2003). Function-
ally characterized selenoproteins serve thiol oxidoreductase
functions with Sec located in enzyme active sites and are directly
involved in catalysis. More than half of the mammalian seleno-
proteins are characterized by a thioredoxin fold, with Sec occu-
pying the position of the catalytic redox cysteine (Cys) in thiore-
doxin (Labunskyy et al., 2014; Reeves and Hoffmann, 2009).
Selenof (Selenoprotein F; 15-kDa selenoprotein; Sep15)
(Gladyshev et al., 1998) is one of the 25 selenoproteins encoded
in the human genome. It consists of an endoplasmic reticulum
(ER)-targeting signal peptide, an N-terminal Cys-rich domain,
and a C-terminal thioredoxin-like domain (Labunskyy et al.,
2009). While it is an ER-resident selenoprotein, Selenof lacks
the ER retention signal. However, it binds UDP-glucose:glyco-
protein glucosyltransferase (UGGT), an ER-resident glycoprotein
folding sensor, through its Cys-rich domain. Thus, binding to
UDP-glucose supports Selenof retention in the ER (Korotkov
et al., 2001; Labunskyy et al., 2009). UGGT recognizes incom-
pletely folded glycoproteins and targets them to the calnexin-
calreticulin-ERp57 system by reglucosylation, thereby allowing
another cycle of maturation (Caramelo and Parodi, 2008; Ham-
mond et al., 1994; Trombetta and Helenius, 2000). This function
prevents an ER-to-Golgi exit of folding intermediates, misfolded
glycoproteins, and immature multimeric complexes, ensuring
that only properly folded glycoproteins are targeted to other
cellular compartments, reach the cell surface, and are secreted
(Anelli and Sitia, 2008; Cabral et al., 2001; Sousa et al., 1992;
Zuber et al., 2001). Prevention of secretion of dysfunctional pro-
teins is complex and specific to particular protein classes, but it
is not well defined (Frand et al., 2000; Spang, 2013).
The tight binding between Selenof and UGGT implies that
Selenof may also be involved in ER quality control, but this
possibility has been difficult to test. It was found that UGGT oc-
curs in both Selenof-bound and Selenof-free forms, whereas
the entire pool of Selenof binds UGGT (Korotkov et al., 2001).
The enzyme activities of both of UGGT1 and UGGT2 are
enhanced by the formation of a complex with Selenof (Ito et al.,
2015; Takeda et al., 2014). Selenof exhibits a redox potential sug-
gestive of a reductase or isomerase function, rather than an
Cell Reports 23, 1387–1398, May 1, 2018 ª 2018 The Author(s). 1387
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oxidase of Cys residues (Ferguson et al., 2006; Labunskyy et al.,
2009). Thus, it is an attractive possibility that Selenof supports
redox quality control for a subset of UGGT client proteins. In
this regard, some secreted glycoproteins, such as immunoglob-
ulins (Igs) that are exceptionally disulfide rich, are potential clients
for theUGGT/Selenof sensor. These proteinsmaybe exemplified
by IgM, which is the major antibody produced upon primary im-
mune response. It is expressed in B cells and circulates in the
blood of all vertebrate species (Cenci and Sitia, 2007; Ehrenstein
and Notley, 2010). IgM is often used to identify acute exposure to
an immunogen or pathogen (Leijh et al., 1979). It triggers the
opsonization of antigens (e.g., infectious microorganisms) and
causes ingested microorganisms to be promptly destroyed by
phagocytes. Glycosylation of IgM is vital to its B cell surface pre-
sentation and secretion (Arnold et al., 2007; Sitia et al., 1984).
Secretory IgM consists of 21 subunits, has a total 51 N-glycans,
and contains 98 intra- and inter-chain disulfide bonds (Hender-
shot and Sitia, 2005). Like glycosylation, disulfide formation in
newly synthesized proteins destined for secretion is an error-
prone process (Dejgaard et al., 2004; Hatahet and Ruddock,
2009). Protein disulfide isomerase and several other ER-resident
thiol oxidoreductases have been extensively studied, but much
of this research focused on the actual process of disulfide bond
formation and isomerization. On the other hand, redox quality
Figure 1. Selenof Deficiency Leads to Ele-
vated Immunoglobulin Levels
(A) Body and spleen weights of WT and Selenof KO
mice (n = 4 per group). Spleen weights are different
between WT and Selenof KO mice (p = 0.02).
13-week old WT and Selenof KO littermates were
used.
(B) IgM analyses in WT and Selenof KO mouse sera
by ELISA. The sera were diluted to 1:12,000, and
anti-IgM antibody was used as a capture antibody.
13-week-old littermates (n = 4 per group)were used.
(C and D) Aliquots of sera from WT and Selenof KO
mice were resolved under reducing SDS-PAGE (C)
or 4–16% non-reducing NativePAGE (D), and blots
were analyzed with anti-Ig-m or anti-Ig-k anti-
bodies. 10 mg serum protein per lane was loaded.
(E) Immunoglobulins were quantified in WT and
Selenof KO sera by ELISA. Blood was withdrawn
from the submandibular vein of 12-week-old male
littermates (n = 8 per group). Sera were diluted to
1:50,000, and anti-Ig (H+L) was used as a capture
antibody. Two-tailed probability values of a
Student’s t test are as follows: IgG2a, p = 0.03;
IgG2b, p = 0.006; IgG2c, p = 0.002; IgG3, p = 0.02;
IgA, p = 0.0004; and IgM, p = 0.02.
Data are expressed as mean ± SD. *p < 0.05;
**p < 0.01; ***p < 0.001; n.s., not significant.
control of secreted glycoproteins has not
been thoroughly addressed.
In the present study, by examining the
consequences of Selenof deficiency in
mice and primary plasma B cell differentia-
tion models (Bertolotti et al., 2010), we
observed elevated secretion of Igs, without
evidenceof enhanced immune function orphenotypesassociated
with the secretory cells. Mouse embryonic fibroblasts (MEFs)
treatedwith chemicals that perturbER-to-Golgi transport reduced
Selenof protein expression, while tunicamycin treatment, which
induces unfolded protein response, elevated Selenof protein
levels. Ina fluorescence-microscopy-basedassay for ER-to-Golgi
transport of the vesicular stomatitis virus (VSV) G protein, Selenof
knockout (KO) MEFs exhibited a significantly delayed transport
function. Proteomic analyses showed depletion of ‘‘antigen pre-
sentation’’ and enrichment of ‘‘ER-to-Golgi anterograde trans-
port’’ in Selenof KO MEFs. Together with other analyses, the
data suggested that Selenof serves a function as a gatekeeper
for Igs and likely other disulfide-rich glycoproteins, thereby
providing redox quality control of secreted glycoproteins.
RESULTS
Systemic Selenof Deficiency in Mice Leads to Elevated
Ig Levels without Altering Immune Functions
Selenof KOmice were fertile, grew and developed normally, and
had no obvious pathologies. However, while wild-type (WT) and
Selenof KO mice had similar body weights, the latter animals
were characterized by mild splenomegaly (n = 6 per group,
p = 0.02) (Figure 1A). By further examining littermate WT and
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Selenof KO mice (n = 8 per group, 12-week-old mice), we found
that Selenof deficiency leads to elevated levels of IgM in serum
(p = 0.0002), based on ELISAs (Figure 1B). Analysis of IgM com-
ponents by western blotting under reducing (Figure 1C) and non-
reducing conditions (Figure 1D) revealed higher levels of both
Ig-m and Ig-k chains in the serum of Selenof KOmice. In addition,
global analyses of Ig abundance showed increased levels of
IgG2a, IgG2b, IgG2c, IgG3, and IgM in Selenof KOmouse serum
(n = 8 per group) (Figure 1E). In contrast, serum protein levels and
their patterning, as analyzed by SDS-PAGE, were not different
between WT and Selenof KO mice (Figure S1), suggesting that
Selenof deficiency preferentially leads to elevation of serum Igs
and possibly other proteins.
Complete blood count (CBC) using Hemavet Systems showed
that all 24 measured and reportable CBC parameters, except
platelet count, were not different between WT and Selenof KO
animals (n = 10 per group, 12-week-old male mice). Platelet
Figure 2. Elevated IgM Secretion by Selenof
KO LPS-Activated B Cells
(A) Growth of LPS-stimulated B splenocytes iso-
lated from WT and Selenof KO mice. The graph
shows B cell growth during differentiation.
(B) IgM secretion measured during plasma B cell
differentiation by ELISA. Two-tailed probability
values of a Student’s t test from day 0 to day 5
are as follows: day 0, p = 0.0091; day 1, p = 0.3891;
day 2, p = 0.18; day 3, p = 5E06; day 4,
p = 0.0003; and day 5, p = 0.0013.
(C) Surface and intracellular IgM expression levels
were measured in plasma B cells at differentiating
day 4 using flow cytometry. MFI, median fluores-
cence intensity of the fluorescently labeled IgM.
(D) Expression of ER proteins in WT and Selenof
KO B cells. Western blotting of Selenof and other
ER proteins with relevance to Selenof function
during B cell differentiation.
(E–G) Kinetics of IgM biosynthesis and transport
were measured by radioactive pulse-chase assays
(E and F) and quantified with ImageJ (G). The
polymerization status of intracellular (E) and
secreted (F) IgM was visualized in non-reducing
conditions (E and F, upper panels), and Ig-m levels
were quantified in reducing blots (E and F, lower
panels). At chase time 0, the levels of intracellular
polymerization intermediates ((m2L2)n) were
increased by 20%, and the Ig-m levels were
50% only slightly higher in Selenof KO plasma
cells. Secreted IgM was more abundant (30–45%)
in the spent media of Selenof KO LPS-activated
splenocytes during the chase.
Data are expressed as mean ± SD. *p < 0.05;
**p < 0.01; ***p < 0.001.
counts of Selenof KO mice were approxi-
mately 20% lower than those of WT
littermates (p < 0.01). In addition, flow-cy-
tometric analysis showed that the propor-
tion of splenic CD4+ and CD8+ T cells, as
well as of CD19+ B cells, were not altered
by Selenof deficiency (Figure S2). Overall,
the data suggested that Selenof defi-
ciency increases Ig levels but does not lead to recognizable
systemic changes in protein abundance or immune defects.
Selenof Deficiency Leads to Elevated Secretion of IgM
during Plasma B Cell Differentiation
High Ig levels in the serum of Selenof KO mice may be the result
of elevated production and/or decreased degradation of Igs. To
characterize how Selenof deficiency alters serum IgM levels, we
analyzed the rate of IgM secretion by activated plasma B cells.
The proliferation rate of B cells, determined by the total number
of cells per milliliter of media, during plasma B cell differentiation
upon lipopolysaccharide (LPS) stimulation, was not affected by
Selenof deficiency (Figure 2A). Without LPS stimulation, IgM
secretion by naive B cells was higher in Selenof KO mice
(day 0). Upon LPS treatment, IgM was secreted at a higher level
during differentiation of splenic B cells isolated from Selenof KO
mice starting from differentiation day 3, and increased IgM
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production continued until termination of the experiment at day 5
(Figure 2B). Using flow cytometry, expression levels of surface
and intracellular IgM were measured. Activated B cells, 4 days
after the LPS treatment, showed significantly higher levels of sur-
face IgM and intracellular IgM in the absence of Selenof
compared to controls (WT cells) (Figure 2C). To determine
whether Selenof deficiency and the resulting excess IgM secre-
tory phenotype resulted in increased ER stress or altered levels
of ER stress-associated proteins during plasma B cell differenti-
ation, we analyzed relevant protein expression by western blot-
ting (Figure 2D). Selenof expression did not change in WT B cells
during differentiation, and, as expected, this protein was not
detected in KO cells. The expression of UGGT1 and UGGT2 pro-
teins, which are the binding partners of Selenof, also was not
affected, and Selenof deficiency did not alter their expression.
As expected, ER stress response markers GRp78 and CHOP
and the antioxidant Prx4 increased, but Selenof deficiency did
not modify their expression patterns. In addition, no clear
changes were observed in the expression of ERp46 and calreti-
culin (CRT). Thus, Selenof deficiency resulted in elevated IgM
secretion but did not lead to (or change the level of) ER stress
during B-to-plasma cell differentiation.
Next, we evaluated the kinetics of IgM synthesis and secretion
during the course of B cell differentiation at day 3 by pulse-chase
analyses (Figures 2E–2G and S3). Primary B splenocytes iso-
lated from WT and Selenof KO mice were pulse-labeled with
35S-labeled amino acids, washed, and chased for 0, 2, or 4 hr.
The total cell lysates (Figure S3A) or immunoprecipitates (Figures
2E and 2F) were resolved by SDS-PAGE under non-reducing
(Figures 2E and 2F, upper panels) or reducing (Figures 2E and
2F, lower panels) conditions, visualized by autoradiography,
and quantified with ImageJ (Figure 2G). Both intracellular (Fig-
ure 2E) and secreted (Figure 2F) IgM levels were higher in
Selenof KO B cells. Secreted IgM polymers were quantified
from the non-reducing SDS-PAGE (Figure 2G). Intracellular and
secreted polymerized IgM ((m2L2)n) levels were increased by
20% at 2 hr of chase in Selenof KOB cells, compared toWT con-
trols. In addition, intracellular Ig-mwasmeasured under reducing
SDS-PAGE conditions and found to be increased 50% at time 0
in Selenof B cells, and the levels of secreted Ig-mwere increased
25–45% during different chase time points (Figures 2E and 2F,
lower panels, and S3B and S3C). These findings further support
the selective elevated secretion of Igs as a consequence of
Selenof deficiency.
Increased Ig Levels in Selenof KO Mice Are Not
Associated with Increased Phagocytosis and Bacterial
Killing Potential
We considered the possibility that elevated Igs in Selenof KO
mice might be functional and might better protect mice from
antigen challenges such as bacterial infection. Since a complete
blood test and lymphocyte levels of Selenof KO mice were not
indicative of major changes in the immune function (Figure S2),
we used a mouse model of acute peritoneal inflammation to
examine Ig-neutrophil-mediated bacteria killing. We challenged
Selenof KOandWTmice in vivo by intraperitonealE. coli injection
and performed in vitro assays using E. coli and S. aureus opson-
ized with sera obtained from WT and Selenof KO mice and then
phagocytosed by neutrophils isolated from WT animals. Addi-
tionally, pHrodo Red E. coli bioparticles were opsonized with
WT or Selenof KO sera and tested in phagocytosis assays.
The sera from WT and Selenof KO mice were equally efficient
in opsonizing, leading to the killing of both tested bacterial
strains (Figure 3A). If anything, the Selenof KO serum appeared
to be less efficient, rather than more efficient, in clearing E. coli
than the WT serum, although this effect did not reach statistical
significance. In vivo clearance of bacterial infection was also not
different between WT and Selenof KO mice (Figure 3B), but
again, Selenof KO mice cleared the E. coli infection slightly
less efficiently than control mice, although this difference
was not statistically significant. In addition, bioparticles with a
pH-sensitive fluorophore were used to quantify particle uptake
by primary B cells or macrophages after opsonization with sera
from WT or Selenof KO mice. As the bioparticles turn red after
internalization, we used flow cytometry to quantify the number
of cells that successfully ingested bioparticles, and we detected
no significant differences between the sera fromWT and Selenof
KO mice (Figure 3C).
To further test the functionality of antibodies in WT versus
Selenof KO sera, we immunized WT and KO animals with the
model antigen NP-OVA (4-hydroxy-3-nitrophenylacetyl hapten
conjugated [NP] to ovalbumin protein [OVA]) and determined
the amount of total as well as NP-specific IgM and IgG anti-
bodies. Selenof KO mice had significantly higher levels of total
IgM and IgG in comparison of the control mice. The amounts
of NP-specific IgM and IgG antibodies, however, were signifi-
cantly reduced in Selenof KO mice (Figure 3D). Overall, the
data showed that elevated Ig levels in Selenof KO mice did not
result in elevated clearance of bacterial infection or phagocytosis
of pathogenic bioparticles in vivo. An in vitro bacterial killing
assay further confirmed that this might not be due to the killing
capacity of neutrophils of Selenof KO mice. Taken together,
these data suggest that the excess of antibodies present in the
sera of Selenof KO mice confer no obvious advantage in the
functional assays utilized.
Selenof-Deficient Cells Are Not More Vulnerable to ER
Stress but Show Changes Associated with ER-to-Golgi
Transport
Since protein synthesis and secretion are linked to ER function
(the compartment where Selenof resides), we further examined
Selenof expression in mouse tissues in comparison with other
proteins relevant to its function. Selenof was expressed in
various organs, with the highest levels in the pancreas and brown
adipose tissue (Figure 4A). A somewhat similar pattern was
observed for UGGT2, whereas UGGT1 was expressed at high
levels across mouse tissues.
We further developed MEFs from WT, Selenof heterozygous,
and Selenof KO littermate mice and examined how protein
expression is altered in these cells in response to ER stress. All
examined ER stressors-thapsigargin (Figure 4B), tunicamycin
(Figure 4C), and brefeldin A (Figure 4D)-induced abundant
expression of GRp78/BiP and CHOP but not of UGGT1 and
calreticulin. Brefeldin A (0.5 mM and 5 mM) and thapsigargin
(5 nM and 50 nM) treatment reduced the expression of Selenof
more than tunicamycin (50 ng/mL and 500 ng/mL). Thus, Selenof
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is not a part of the canonical, chemical-induced ER stress
response pathway but may be involved in later steps of protein
synthesis and trafficking, such as ER-to-Golgi transport.
To further examine the role of Selenof in ER-to-Golgi trans-
port, an in vivo transport assay using the temperature-sensitive
variant of VSVG protein (ts045-VSVG)-EGFP was performed
(Hirschberg et al., 1998; Vanhoutte et al., 2016). WT, heterozy-
gous (Het), and Selenof KO MEFs were transduced with the
ts045-VSVG-EGFP-expressing adenovirus, and the fluores-
cence intensity of VSVG in whole cells and the ER-to-Golgi
positive area was measured. Expression of VSVG in MEFs
was synchronized prior to the VSVG crossing the Golgi by
compartment progression. We found that the transport vesicles
exiting the ER and trafficking to the ER-to-Golgi intermediate
compartment (ERGIC) were delayed in Selenof KO MEFs,
compared to WT cells (Figures 5A and 5B). Ten min after the
cells shifted from non-permissive temperature to 32C, VSVG
trafficking in Selenof KO MEFs was delayed approximately
20% (p < 0.01), compared to WT cells. It is possible that the de-
layed complete clearance of the VSVG in Selenof KO MEF is a
consequence of the abundant VSVG that is partially misfolded.
These findings support the notion that Selenof plays a role as a
Figure 3. Elevated Immunoglobulins in Se-
lenof Deficiency Are Partially Nonfunctional
(A) In vitro clearance of bacterial cells by WT and
Selenof KO serum. Shown are data for E. coli (left)
and S. aureus (right).
(B) In vivo clearance of bacterial infection by WT
and Selenof KOmice. In vivo killing of E. coli byWT
and Selenof KO mice, assessed as the number of
remaining E. coli cells.
(C) Uptake of pHrodo E. coli bioparticles by B cells
(left) and macrophages (right) from WT mice that
were opsonized by WT or Selenof KO serum.
(D) Total and NP-specific IgM and IgG antibody
production in WT or Selenof KO mice after immu-
nization with NP-OVA.
Data are expressed as mean ± SD. *p < 0.05;
**p < 0.01; n.s., not significant.
gatekeeper and is involved in protein
folding and sorting, and ER-to-Golgi
transport.
Because Selenof KO animals were
characterized by mild splenomegaly (Fig-
ure 1A), we also analyzed gene expres-
sion changes in this organ, followed by
Ingenuity Pathway Analysis (IPA). Com-
parison of Selenof KO mice and WT litter-
mate controls revealed several IPA ‘‘asso-
ciated diseases and biofunctions’’ that
included the categories ‘‘metabolism of
protein’’ (198 molecules), ‘‘synthesis of
protein’’ (91 molecules), ‘‘catabolism
of protein’’ (121 molecules), and ‘‘ER
stress response’’ (42 molecules, Z score:
0.887; p = 0.00002) (Data S1). Among
the gene changes that contributed, the
top canonical pathway identified within the ER stress response
related to the ‘‘unfolded protein response.’’ These findings sup-
port the role of Selenof in ER functions.
Inducers of ER stress, such as nutrient starvation, lead to the
accumulation of unfolded proteins within the ER lumen and
affect the ER-to-Golgi secretory pathway. Energy deprivation
blocks the Golgi complex and the trans-Golgi network through
a response mainly triggered by impaired coat protein-1 (COPI)-
dependent retrograde transport from the Golgi to the ER (Chen
et al., 2014). Hence, we tested whether Selenof impacted the
ER-to-Golgi secretory pathway under conditions of ER stress
induced by serum starvation (Figure S4). Quantitative global pro-
teomic analyses in WT and Selenof KO MEFs were carried out,
and the associated biological pathways were evaluated (Data
S2). A total of 7,467 proteins were quantified by tandem mass
spectrometry (MS/MS) in MEFs maintained in a serum-free cul-
ture condition. At a p value of < 0.05, 198 proteins were found
to be decreased and 138 proteins increased (n = 3) in Selenof
KO MEFs. The differentially expressed proteins (p < 0.05) were
further analyzed and visualized using Reactome, STRING,
and DAVID. Proteins decreased in Selenof KO cells (Fig-
ure 6A) were associated with ‘‘membrane part’’ (Gene Ontology
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[GO]: 0011125; false discovery rate [FDR], 4.45E17) and ‘‘regu-
lation of cellular localization’’ (GO: 0032879; FDR, 9.43E05).
Seventy-three of these proteins were also associated with ‘‘cat-
alytic activity’’ (GO: 0003824; FDR, 0.0004189). ‘‘Porin activity’’
(GO: 0015288) was also enriched (FDR, 0.000114). Proteins
with elevated levels in Selenof KO MEFs were associated with
several pathways, most notably with ‘‘coated vesicle mem-
brane’’ (GO: 0030662; FDR, 0.000196) and ‘‘mitotic cell cycle’’
(GO: 0000278; FDR, 0.0194) (Figure 6B).
To examine protein-protein interactions involving Selenof and
UGGT1, immunoprecipitation was performed from liver lysates
of WT and Selenof KO mice using antibodies against Selenof
and UGGT1, followed by MS/MS analyses (Figure S5;
Data S2). The use of Selenof antibodies revealed 44 proteins
(p < 0.05) affected by Selenof deficiency, whereas the use
of UGGT1 antibodies revealed 63 proteins. Five proteins
(Hsd17b4, Plec, Rpl11, Scp2, and Selenof) were detected by
using both antibodies. Forty-three proteins that were enriched
with Selenof antibodies were further analyzed using STRING
(Figure 6C). ‘‘Structural molecule activity’’ was the strongest
association: 17 of the 43 proteins belonged to this functional
category (GO: 0005198; FDR, 3.76E15). In addition, cellular
components associated with ‘‘intermediate filament’’ (FDR,
5.51E14) and ‘‘extracellular exosome’’ (FDR, 8.3E08) were
Figure 4. Selenof Deficiency Does Not Lead
to ER Stress
(A) Expression pattern of Selenof and other rele-
vant proteins across mouse tissues.
(B–D) Expression of Selenof and other relevant
proteins in MEFs from WT, heterozygous, and
Selenof KO mice subjected to ER stressors thap-
sigargin (B), tunicamycin (C), and brefeldin A (D).
WT, heterozygous, and KO MEFs were treated
with two concentrations of stressors along with
control (DMSO treated): thapsigargin (5 nM and
50 nM), tunicamycin (50 ng/mL and 500 ng/mL),
and brefeldin A (0.5 mM and 5 mM). Proteins as-
sayed are shown on the left.
enriched. Other notable enriched func-
tions were ‘‘cellular lipid catabolic pro-
cess’’ (GO: 0044242; FDR, 0.000532),
and the Kyoto Encyclopedia of Genes
and Genomes (KEGG) pathway of
‘‘peroxisome’’ (KEGG: 04146; FDR,
2.69E06). Among proteins differentially
immunoprecipitated with UGGT1 anti-
bodies from WT and Selenof KO livers,
30 proteins were associated with ‘‘extra-
cellular exosome’’ (GO: 0070062; FDR,
3.41E11) (Figure 6D). ‘‘Poly(A) RNA
binding’’ (GO: 0044822; FDR, 7.21E06)
was also enriched. The Reactome-
enriched biological pathways included
‘‘antigen presentation: folding, assembly,
and peptide loading,’’ ‘‘COPII (Coat Pro-
tein 2)-mediated vesicle transport,’’ and
‘‘ER-to-Golgi transport and its associated
pathways,’’ such as vesicle transport and ER-phagosome
pathway (Tables 1, S1, S2, and S3). The DAVID functional anno-
tation tool similarly identified pathways associated with the ER to
the trans-Golgi network (Table S3), including ‘‘Golgi vesicle
transport’’ (p = 4.20E05), ‘‘cytoplasmic membrane-bounded
vesicle’’ (p = 1.10E04), and ‘‘membrane-bounded vesicle’’
(p = 1.70E04).
DISCUSSION
Selenof has been an enigmatic protein, many efforts to address
its function notwithstanding (Hu et al., 2001; Kasaikina et al.,
2011; Kumaraswamy et al., 2002; Labunskyy et al., 2005; Novo-
selov et al., 2006). Being a selenoprotein with a thioredoxin fold,
and having Sec in the position of the redox-active Cys in thiore-
doxin, Selenof was expected to function as a thiol oxidoreduc-
tase. Its redox potential is 225 mV, which is between that of
thioredoxin (270 mV) and protein disulfide isomerase
(175 mV); therefore, Selenof is likely to act as a reductase or
isomerase (Ferguson et al., 2006). All functionally characterized
selenoproteins are oxidoreductases and the majority of thiore-
doxin-fold proteins are oxidoreductases. Selenof is localized in
the ER due to its strong binding to UGGTs, whose function is
to maintain glycoprotein quality control in the ER. Upon binding
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of Selenof to UGGT1 or UGGT2, the glucosyltransferase activ-
ities of these proteins are increased (Takeda et al., 2014).
Together with the previously described oxidative stress-like phe-
notypes that characterize Selenof deficiency in cell culture and
animal models (Ferguson et al., 2006; Kasaikina et al., 2011), a
possible function of Selenof was thought to be related to redox
quality control of UGGT targets. However, it was difficult to
examine this function.
Our findings support the idea that Selenof participates in the
complex secretome gatekeeping function, likely assisting newly
synthesized glycoproteins as they exit the ER or during their
trafficking between the ER and the Golgi. While mice lacking
Selenof are viable and fertile and have no gross morphological
abnormalities, Selenof deficiency led to elevated levels of serum
Igs-in particular, IgM-as well as to mild splenomegaly. We found
that the elevated serum IgM levels were due to increased secre-
tion of these molecules. The data further suggest that Selenof is
a gatekeeper of UGGT targets translocated from the ER to the
Golgi apparatus.
Secreted disulfide-rich proteins are characterized by a high
rate of incorrect disulfide formation, as well as significant varia-
tion in glycosylation (Buchberger et al., 2010; Sevier and Kaiser,
2002). Although the calnexin-calreticulin-ERp57 system permits
incorrectly glycosylated proteins to pass through an additional
round of maturation (Anelli and Sitia, 2008), it has been unclear
how the disulfide quality control is maintained during this
process, since many UGGT clients are rich in disulfides. Selenof
nicely fits this role, although it may not be the exclusive oxidore-
ductase in this process. It appears that Selenof deficiency
weakens glycoprotein redox quality control, allowing some
glycoproteins with incorrect disulfides to be secreted. If so, a
subset of secreted disulfide-rich glycoproteins may bypass the
checkpoint, and the secreted pool would consist of a mixture
of functional and non-functional molecules. In the absence of
Selenof, the latter would bypass also the ERp44 quality control
system that operates beyond the ER in a pH-dependent way
(Anelli et al., 2015).
Our findings support this model. While the levels of IgM, a
highly glycosylated molecule with numerous inter- and intra-
disulfide bridges, were elevated in Selenof KO mice, in vitro
and in vivo clearance of bacterial infection was not affected.
The fact that Selenof deficiency does not lead to measurable
ER stress is also consistent with this possibility. In addition,
Selenof protein expression was decreased upon brefeldin
A and thapsigargin treatments that inhibit ER-to-Golgi transport
and induce retrograde protein transport between these compart-
ments. Also, confocal images of ts045-VSVG-EGFP-expressing
MEFs confirmed that the VSVG-EGFP cargo exiting from the
Golgi apparatus was delayed but, ultimately, could be
completed in Selenof KO cells. Newly synthesized, secreted
non-functional glycoproteins would pass through the ER and
Golgi in the absence of Selenof, so the ER compartment itself
would be subjected to similar levels of stress in WT and Selenof
KO cells. It is unclear whether elevated levels of non-functional
Igs directly cause splenomegaly, as this phenotype may also
result from other processes, but at least this phenotype is
consistent with the predicted function of Selenof. Nutrient-star-
vation-induced ER stress leads to the accumulation of unfolded
proteins within the ER lumen and affects the ER-to-Golgi secre-
tory pathway. Regulatory mechanisms preventing secretion of
dysfunctional proteins from cells may be complex and involve
multiple proteins or even pathways. Perturbations of ER homeo-
stasis mediate ER stress through translational attenuation,
upregulation of the ER chaperone functions, and degradation
of misfolded proteins. It is also possible that some of the
changes observed in Selenof KO mice are an outcome of the
ER-stress-associated secondary or feedback mechanisms.
Our quantitative microarray analyses in spleen indicated various
mechanisms related to ER stress and protein synthesis affected
by systemic Selenof deficiency in mice. Quantitative global pro-
teomic analyses revealed that proteins differentially expressed
between WT and Selenof KO MEFs were primarily enriched in
the pathways associated with the ER-to-Golgi transport. Pro-
teins that were differentially expressed and involved in antigen
presentation and vesicle transport categories included Sec23a,
Sec24d, Sec16b, Sec23ip, Uso1, Rab1b, and Mr1. These find-
ings support the idea that Selenof functions as a gatekeeper
and that disruption of this gene significantly affects the critical
ER-to-Golgi transition.
Most previous research on thiol oxidoreduction in the ER dealt
with the formation of disulfide bonds, whereas the redox gate-
keeper function remained poorly characterized. Nevertheless,
Figure 5. Delayed ER-to-Golgi Trafficking in
Selenof KO MEFs
(A) Immunofluorescence micrographs of WT, het-
erozygous, and Selenof KO MEFs expressing
adenoviral ts045-VSVG-EGFP and a Golgi marker.
Representative images show the overlapping area
where the VSVG-EGFP is retained in the ER-to-
Golgi area, 10 min after the cells were transferred
from the restrictive temperature (40C) to the
permissive temperature (32C). Scale bars: 10 mm.
(B) Quantification of VSVG fluorescence retained in
the ER-to-Golgi area. Three cell lines per each
genotype and more than 10 cells per each field
were evaluated. Immunofluorescence microscopy
images were analyzed by ImageJ. *p < 0.05;
**p < 0.01.
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this function is expected to be selected during evolution (Sun
et al., 2014), particularly with regard to secreted disulfide-rich
proteins, as otherwise organisms would need to invest large
amounts of energy in producing and then detecting and degrad-
ing secreted non-functional molecules. The gatekeeper function
of Selenof is likely not limited to IgM or, more generally, to Igs.
Selenof is expressed in all cells and appears to target a subset
of secreted proteins. It is possible that the phenotype we
observed in activated B cells was better exposed due to the
specialized function of these cells in secreting large quantities
of disulfide-rich glycoproteins.
Our work was performed using mouse models, which
tolerate Selenof deficiency and exhibit relatively mild pheno-
types, at least in the lab setting. Interestingly, based on the
analysis of more than 60,000 human exomes (http://exac.
broadinstitute.org/) (Lek et al., 2016), we found that the loss-
of-function SELENOF alleles (functionally equivalent to hetero-
zygous KO) are depleted 5-fold compared to the expected
occurrence, whereas the occurrence of synonymous and
missense mutations in SELENOF is as expected. This observa-
tion suggests that the SELENOF-supported function may be
more important in long-lived humans than in short-lived mice.
Selenof has a paralog, Selenom, in both mice and humans,
and it is also a selenoprotein. However, Selenom does not
bind UGGTs or increase the activity of UGGTs (Ito et al.,
2015; Takeda et al., 2014). We speculate that it may serve
some other subsets of disulfide-containing proteins that pass
through the ER.
Overall, this study identifies a new function of the selenopro-
tein oxidoreductase Selenof: a gatekeeper of secreted
disulfide-rich glycoproteins. The data suggest that it blocks
these proteins from secretion when they possess incorrectly
formed disulfides or have some other redox-related errors in
their Cys residues that inhibit their functions, so the erroneous
proteins are subjected to additional rounds of maturation in
the ER.
EXPERIMENTAL PROCEDURES
Materials
Tunicamycin, brefeldin A, and thapsigargin were from Tocris Bioscience
(Bristol, UK); and lipopolysaccharide (LPS; L2637), SIGMAFAST OPD (o-phe-
nylenediamine), and 2-mercaptoethanol were from Sigma (St. Louis, MO,
USA). Cell culture media (DMEM and RPMI), antibiotics, non-essential amino
acids, sodium pyruvate, N-glutamine, insulin-transferrin-selenium (ITS-G,
1003), serum, and ammonium-chloride-potassium (ACK) lysis buffer were
from Invitrogen. For western blot analysis, NuPAGE 10% Bis-Tris and
NativePAGE 4–16%Bis-Tris Gel systems (Invitrogen) were used. The following
antibodies for western blotting were used: anti-b-Actin (Sigma), anti-Selenof
(NCIR128A, Abcam), anti-Peroxiredoxin 4 (Prx4, AbFrontier, Korea), anti-
UDP-glucose:glycoprotein glucosyltransferase 1 and anti-UDP-glucose:gly-
coprotein glucosyltransferase 2 (UGGT1 and UGGT2, Novus Biologicals),
anti-calreticulin (Cell Signaling Technology), anti-CCAAT/anti-enhancer-bind-
ing protein homologous protein (CHOP, Abcam), anti-46 kDa endoplasmic
Figure 6. Network Analysis of Enriched
Pathways and Interactions
(A and B) WT and Selenof KO MEFs were cultured
in serum-free media and subjected to quantitative
proteomics analysis. Enriched proteins (p < 0.05,
138 up- and 198 down-regulated in Selenof KO)
were further analyzed and visualized with STRING.
Proteins with catalytic activity are marked with red
bubbles. The functions ‘‘membrane part’’ and
‘‘regulation of cellular localization’’ were the most
decreased in Selenof KO cells. Mitochondrial
envelope proteins were decreased in Selenof KO
(A). Proteins with increased levels in Selenof KO
MEFs belonged to the clusters ‘‘Coated vesicle
membrane/Golgi apparatus’’ (circled in purple),
‘‘Nucleolus’’ (circled in green), and ‘‘Mitotic cell
cycle’’ (circled in red) (B).
(C and D) Selenof and UGGT1 interacting proteins
and the associated enriched pathways. Proteins
from WT and Selenof KO livers were immunopre-
cipitated with antibodies against Selenof (C) or
UGGT1 (D), followed by MS/MS analysis. Proteins
identified (p < 0.05) were further analyzed. Selenof
antibodies enriched 44 proteins belonging to
‘‘structural molecule activity’’ (marked with red
bubbles). Four protein clusters were identified and
visualized: ‘‘cellular lipid catabolic process’’
(circled in blue), ‘‘Cytosolic ribosome’’ (circled in
yellow), ‘‘Intermediate filament’’ (circled in green),
and Selenof along with UGGT1 (C). UGGT1 anti-
bodies enriched 63 proteins belonging to ‘‘extra-
cellular exosome’’ (marked with red bubbles).
A cluster with a function ‘‘Poly(A) RNA binding
proteins’’ is circled in green in (D). Disconnected
nodes are not shown.
1394 Cell Reports 23, 1387–1398, May 1, 2018
reticulum protein (ERp46, Abcam), anti-glucose regulated protein 78 (GRp78,
Abcam), and rabbit anti-mouse IgM antibody (cat# 61-6800, Zymed). For ELI-
SAs, goat anti-mouse IgG1-HRP (horseradish peroxidase), goat anti-mouse
IgA-HRP, goat anti-mouse IgG2a-HRP, goat anti-mouse IgG2b-HRP, goat
anti-mouse IgG2c-HRP, goat anti-mouse IgG3-HRP, goat anti-mouse IgE-
HRP, and anti-IgM m-HRP were from SouthernBiotech. CellLight Golgi-RFP,
BacMam 2.0, and pHrodo Red E. coli BioParticles were from Thermo Fisher
Scientific. Mouse B cell and neutrophil isolation kits were fromMiltenyi Biotec.
BD Microtainer serum separator tubes were from BD Biosciences. Bacterial
strains Staphylococcus aureus (S. aureus, strain 10390) and E. coli (E. coli,
strain 19138) were from the American Type Culture Collection (ATCC).
Mice
Selenof KO mice were generated as previously described (Kasaikina et al.,
2011) and backcrossed to C57BL/6J background for at least 10 generations.
WTandSelenofKOmice for thedescribedexperimentswereproducedbymat-
ing heterozygous animals. Genotyping was performed by PCR using Selenof
gene-specific primers (forward [F]1: GCA GCT CTT GCG ATC TTC TT and
reverse [R]1: TTT GGC CAG ATA CCA GGA AG) and inserted Neo-cassette
specific primer (F2: TCG CCT TCT TGA CGA GTT CT). Littermate male mice,
aged 8 to 14 weeks, were used for all experiments, except for the generation
of Selenof MEF cells. Experimental animal protocols were approved by the
Institutional Animal Care and Use Committees of Brigham and Women’s
Hospital, Harvard University, and University of Nebraska-Lincoln.
Generation of MEFs and Cell Culture
Primary MEFs were generated bymating Selenof heterozygous animals. Preg-
nant females were sacrificed on day 13.5 post-coitum, embryos were surgi-
cally removed, and fibroblast cells were prepared in culture. Each embryo
was cultured separately and was genotyped for the disruption of the Selenof
gene. Selenof WT, heterozygous, and KO cells were generated from a single
litter, and same-passage cells were used for the study. MEFs were cultured
in DMEM (Invitrogen) supplemented with 1 mM non-essential amino acids,
10% fetal bovine serum, 1% penicillin-streptomycin (Pen/Strep), and
0.5 mmol/L 2-mercaptoethanol (b-ME). MEFs used in the experiments were
in passages 3 to 7 without immortalization.
Selenof WT, heterozygous, and KO MEF cells were treated with ER-stress-
inducing agents. For tunicamycin (TM), brefeldin A (BFA), and thapsigargin
(TG) treatments, 1,0003 stock solutions were prepared in DMSO, and an equal
volume of DMSO alone (0.1%, v/v) was applied to cell culture as a control. MEF
cells (WT, heterozygous, and KO) derived from a single litter and same
passage number were plated at a concentration of 106 cells per 10-cm dish
and allowed to attach overnight prior to application of ER-stress-inducing
reagents. The cells were treated with tunicamycin (50 ng/mL or 500 ng/mL),
TG (5 nM or 50 nM), brefeldin A (0.5 mM or 5 mM), or DMSO (0.1%, v/v). After
24 hr of treatment with ER-stress-inducing agents, cell culture plates were
briefly washed twice with ice-cold PBS, and the attached cells were directly
lysed with SDS sample buffer for protein analysis.
Liquid Chromatography-Tandem Mass Spectrometry Analysis and
Pathway Enrichment Analysis
To subject cells to serum starvation, MEFs derived from littermate embryos
(three WT and three Selenof KO) were seeded in 150-mm dishes for 24 hr
and washed twice in PBS, and the culture media were replaced with
phenol-red-free RPMI 1640 media supplemented with insulin-transferrin-se-
lenium (1 g/L, 0.55 g/L, and 0.67 mg/L as sodium selenite, respectively).
Three days later, adherent cells were lysed in ice-cold protein lysis buffer
(50 mM HEPES [pH 7.5], 150 mM KCl, 2 mM EDTA, 1 mM NaF, 0.5% [v/v]
NP-40, 0.5 mM DTT, and protease inhibitor cocktail [Roche, EDTA-free],
and 10 mM N-ethylmaleimide). After enzymatic digestion, an aliquot of
Table 1. Pathway Enrichment Analysis of 336 Proteins Differentially Expressed between Selenof KO and WT Mouse Embryonic
Fibroblast Cells
Pathway Proteins Found Proteins Total Ratio p Value FDR
Antigen presentation: folding, assembly, and peptide loading of
class I MHC
14 118 0.011 1.46E06 0.00115
Laminin interactions 6 31 0.003 1.21E04 0.0476
COPII (Coat Protein 2)-mediated vesicle transport 8 75 0.007 5.36E04 0.103
Endosomal/vacuolar pathway 9 97 0.009 6.60E04 0.103
Antigen processing-cross-presentation 12 176 0.016 1.32E03 0.162
ER-phagosome pathway 11 154 0.014 1.45E03 0.162
Class I MHC-mediated antigen processing and presentation 18 368 0.033 3.87E03 0.379
ER-to-Golgi anterograde transport 10 157 0.014 5.22E03 0.407
Transport to the Golgi and subsequent modification 12 212 0.019 5.82E03 0.414
WNT5A-dependent internalization of FZD2, FZD5, and ROR2 2 5 0 6.66E03 0.433
Golgi cisternae pericentriolar stack reorganization 3 17 0.002 8.35E03 0.501
Constitutive signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555)
translocation mutant
2 8 0.001 1.63E02 0.558
Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) translocation
mutant
2 8 0.001 1.63E02 0.558
Non-integrin membrane-ECM interactions 5 61 0.006 1.68E02 0.558
Interferon alpha/beta signaling 8 138 0.013 1.97E02 0.558
5-Phosphoribose 1-diphosphate biosynthesis 2 9 0.001 2.03E02 0.558
CHL1 interactions 2 10 0.001 2.46E02 0.558
Interferon gamma signaling 9 174 0.016 2.64E02 0.558
Zinc influx into cells by the SLC39 gene family 2 11 0.001 2.94E02 0.558
Sema4D-induced cell migration and growth-cone collapse 3 28 0.003 3.08E02 0.558
The Reactome pathway database was used for enrichment analysis. p < 0.05.
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100 mg peptide per condition was fractionated and then analyzed by liquid
chromatography-tandem mass spectrometry (LC-MS/MS) using an Orbitrap
Fusion Lumos (Thermo Fisher Scientific). Mass-spectrometry data were
searched using Sequest and filtered to a 1% FDR at the protein level to
generate the target protein list. Proteins that are differentially expressed
with a p value less than 0.05 between Selenof WT and KO MEFs were further
analyzed for pathway enrichment. Protein interaction databases Reactome
(Fabregat et al., 2016), STRING (Szklarczyk et al., 2017), and DAVID (Huang
et al., 2009) were used for network analyses. In a separate experiment,
immunoprecipitation (IP) was performed from livers of WT and Selenof KO
with antibodies against Selenof or UGGT1. Livers were perfused with PBS
to remove blood prior to tissue collection. Antibodies were first conjugated
to magnetic beads to prevent co-elution using a Dynabeads Antibody
Coupling Kit prior to performing IP. Proteins eluted using each antibody
were subjected for MS/MS analysis for protein identification and
quantification.
Splenic B Cell Isolation and Differentiation
Spleens of WT and Selenof KO mice were removed aseptically and mashed
through cell strainers. The splenocytes were prepared by lysing red blood cells
using ACK lysis buffer. Splenic B cells were further purified by magnetic isola-
tion with a mouse B cell isolation kit by depletion of non-B cells (Miltenyi
Biotec) (Bertolotti et al., 2010). Pre-splenic B cells of WT and Selenof KO
mice at a concentration of 2 3 106 cells per milliliter were cultured in a
flask with RPMI medium containing 10% endotoxin-free fetal calf serum,
100 U/mL penicillin/streptomycin, 1 mM sodium pyruvate, 2 mM N-glutamine,
and 50 mM b-ME. Primary B cells were activated by the addition of 20 mg/mL
LPS in culture media. Daily, a one-third volume of culture media was replaced
with fresh RPMImedium containing b-ME and LPS to avoid risk of starvation or
oxidative stress. A portion of the cells was harvested daily for cell count and at
days 0, 1, 3, and 5 for protein analyses. Cell proliferation curves were plotted
by counting putative cell numbers (per milliliter of culture media) on each day
after LPS-stimulated plasma B cell activation.
Immunoglobulin Production Assay
Secreted IgM levels during B cell activation were measured daily using ELISA.
See the Supplemental Experimental Procedures for full details.
ELISA
Analysis of antigen-specific Ig titers in serum and B cell culture media was
performed with capture ELISA. See the Supplemental Experimental Proced-
ures for full details.
Flow Cytometry
Flow cytometry was performed on an LSR II instrument (BD Biosciences), and
data were analyzed using FlowJo v10.1 (FlowJo). See the Supplemental
Experimental Procedures for full details.
Neutrophil Isolation for Bacteria Killing Assay
Murine bone-marrow-derived neutrophils were isolated from 12-week-old
C57BL/6J WT male animals with a Neutrophil Isolation Kit (Miltenyi Biotec).
See the Supplemental Experimental Procedures for full details.
In Vitro and In Vivo Bacteria Killing Assays
Fresh overnight cultures of S. aureus (ATCC strain 10390) and E. coli (ATCC
strain 19138) were used for in vitro bacteria killing assays, and E. coli cells
were used for in vivo assay. See the Supplemental Experimental Procedures
for full details.
pHrodo Red Bead Uptake
B cells and macrophages from WT mice were purified using magnetic isola-
tion by depleting non-B cells or positively selecting for CD11b+ cells,
respectively (Miltenyi Biotec). The purified cells were incubated in R10 me-
dium with 10% sera collected from WT or Selenof KO mice, and pHrodo
Red E. coli BioParticles were added. After 2 hr, the in vitro uptake of pHrodo
Red beads by B cells and macrophages was determined using flow
cytometry.
Mouse Immunization and NP-Specific Antibody Production
Six- to 12-week-oldWT or Selenof KOmicewere immunized with 100 mgNP16-
OVA (BiosearchTechnologies) ina1:1H37RAcompleteFreund’s adjuvant (CFA;
DIFCO) emulsion. The emulsion was injected subcutaneously into the left and
right flanks of each experimental mouse. 14 days after immunization, NP-spe-
cific antibody titers were measured by the incubation of serum for 1 hr in ELISA
plates coatedwith NP16-BSA (Biosearch Technologies), followed by incubation
with alkaline-phosphatase-conjugated IgG-detection and IgM-detection anti-
bodies (1030-04;SouthernBiotech). The level ofactivitywasmeasuredasoptical
density (OD) units using a Spectramax ELISA plate reader (Molecular Devices).
VSVG Transport Assay
Anterograde transport of VSVG-EGFP in WT, heterozygous, and Selenof KO
MEFs was analyzed using the ts045-VSVG-EGFP (kindly provided by Dr. Jeff-
ery D. Molkentin) as described previously (Vanhoutte et al., 2016). Briefly, 48 hr
after adenoviral transduction, cells were co-infected with CellLight Golgi-RFP
Bacmmam 2.0 and incubated at 40C for 20 hr to retain the VSVG-EGFP in the
ER. To measure the co-localization of VSVG-EGFP during the ER-to-Golgi
transit, cells were shifted to 32C, allowing the VSVG-EGFP to traffic to the
Golgi apparatus. Three independent MEF lines per each genotype were
tested. Representative confocal images of VSVG-EGFP fluorescence overlap-
ping with Golgi-RFP were captured (n = 10 per each MEF line). Fractions of
VSVG-EGFP retained in the Golgi apparatus at 10 min after being released
were further analyzed. All images were captured, analyzed, and quantified
with the ImageJ program (NIH), and overlapping signals were measured.
Radioactive Pulse-Chase Assay
Kinetics of IgM biosynthesis and transport were measured with a radioactive
pulse-chase assay (Cals et al., 1996; Mezghrani et al., 2001) in primary B cells
isolated from WT and Selenof KO mice. See the Supplemental Experimental
Procedures for full details.
Statistical Analyses
Data are expressed as the mean ± SD as indicated. Two-tailed Student’s
t tests were used for comparing different groups of samples, and significant
differences were defined as *p < 0.05, **p < 0.01, and ***p < 0.001, unless
otherwise stated.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, three tables, and three data files and can be found with this article
online at https://doi.org/10.1016/j.celrep.2018.04.009.
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